From: Shortening of treatment duration in patients with chronic hepatitis C genotype 2 and 3 - impact of ribavirin dose - a randomized multicentre trial
SVR
relapse
NR
Mean baseline HCV RNA (Mio IU/mL)
0.76 ± 1.58
1.84 ± 3.28
0.96 ± 0.58
Mean Body weight (kg) ± SD
69 ± 13
76 ± 18
71 ± 8
Mean BMI ± SD
23 ± 4
25 ± 5
24 ± 2
Mean Age, years ± SD
34 ± 9
44 ± 9
50 ± 16
Sex, male/female ± SD
17/14
14/4
1/2